Resmed Overview
Resmed Target Price
Analysts' 12-month price predictions for RMD.
Share Price
$245.04
Average Target Price
$259.75
6% upside
6% upside4 analysts in the last 4 months
High: $274 | Low: $240
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-24 | KeyBancBrett Fishbin | $274 | 11.8% upside |  |
| 2025-04-16 | Mizuho SecuritiesAnthony Petrone | $265 | 8.1% upside | |
| 2025-03-05 | Stifel Nicolaus | $240 |  2.1% downside | |
| 2025-01-31 | Piper SandlerAdam Maeder | $260 | 6.1% upside | |
| 2024-12-12 | Stifel NicolausJonathan Block | $250 | 2% upside | |
| 2024-10-01 | RBC CapitalCraig Wong-Pan | $224 | 8.6% downside | |
| 2024-09-23 | Robert W. BairdJoe Vruwink | $280 | 14.3% upside | |
| 2024-09-18 | Wolfe ResearchMike Polark | $180 | 26.5% downside | |
| 2024-04-10 | RBC CapitalCraig Wong-Pan | $187 | 23.7% downside | |
| 2024-04-01 | Stifel NicolausMike Matson | $224 | 8.6% downside | |
| 2023-10-27 | OppenheimerSuraj Kalia | $175 | 28.6% downside | |
| 2023-09-06 | NeedhamMike Matson | $180 | 26.5% downside | |
| 2022-06-20 | RBC CapitalCraig Wong-Pan | $244 | 0.4% downside | |
| 2022-04-29 | RBC Capital | $233 | 4.9% downside | |
| 2021-10-14 | OppenheimerSuraj Kalia | $312 | 27.3% upside | |
| 2021-08-04 | Morgan StanleySean Laaman | $250 | 2% upside | |
| 2021-07-28 | JefferiesAnthony Petrone | $240 | 2.1% downside | |